Immunochemical characterization of type a botulinum neurotoxin in its purified and complexed forms

By Ram Singh B.   Lopes T.   A. Silvia M.  

Toxicon, Vol. 34, Iss. 2, 1996-02 ,pp. : 267-275

Elsevier

Access to resources Recommend Favorite

Interaction between botulinum neurotoxin type A and ganglioside: ganglioside inactivates the neurotoxin and quenches its tryptophan fluorescence

By Kamata Y.   Yoshimoto M.   Kozaki S.  

Toxicon, Vol. 35, Iss. 8, 1997-08 ,pp. : 1337-1340

Elsevier

Access to resources Recommend Favorite

Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants

By Jensen M.J.   Smith T.J.   Ahmed S.A.   Smith L.A.  

Toxicon, Vol. 41, Iss. 6, 2003-05 ,pp. : 691-701

Elsevier

Access to resources Recommend Favorite

Development of recombinant vaccines for botulinum neurotoxin

By Smith L.A.  

Toxicon, Vol. 36, Iss. 11, 1998-11 ,pp. : 1539-1548

Elsevier

Access to resources Recommend Favorite

Separation of the components of type A botulinum neurotoxin complex by electrophoresis

By Sharma S.K.   Ramzan M.A.   Singh B.R.  

Toxicon, Vol. 41, Iss. 3, 2003-03 ,pp. : 321-331

Elsevier

Access to resources Recommend Favorite